N.J. Lawmakers Seek Ban on Cough Medicine to Minors September 4, 2008
News Summary
The sale of medications containing dextromethorphan (DXM) -- commonly found in cough and cold medicines -- to individuals under age 18 would be prohibited in New Jersey if lawmakers approve a measure sponsored by a pair of state senators, the Newark Star-Ledger reported Sept. 4.
Sens. Barbara Buono and Tom Kean Jr. are backing the proposed ban, saying that misuse of drugs containing DXM is a growing problem. Similar legislation has been proposed in other states and in Congress. "The abuse of dextromethorphan is a growing problem in New Jersey and across the United States," Buono said. "Because the drugs are so readily available to kids, abuse can be easily hidden from even the most involved parent."
Popular over-the-counter drugs containing DXM include Robitussin, NyQuil, Contac, Coricidin, Delsym, Dimetapp, Mucinex, PediaCare, Sudafed, Theraflu and Triaminic. Misuse of such drugs can cause a variety of health problems, such as hallucinations, high blood pressure, blurred vision, loss of motor control, and rapid heartbeat.
In New Jersey, 205 teens were treated for problems related to DXM use last year, according to state officials.
Federal legislation to ban sales of products containing DXM to those under age 18 is sponsored by Sen. Joe Biden (D-Del.). Similar bills are pending in Maryland, Georgia, Oklahoma, and Rhode Island.
COMMENTS ON THIS ARTICLE: